Clinical trial
The Study of Metabolic and Cardiac Vascular Risk in Patients With Polycystic Ovary Syndrome
NCT01114659 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study of Metabolic and Cardiac Vascular Risk in Patients With Polycystic Ovary Syndrome
- Lead sponsor
- Taipei Medical University WanFang Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- October 31, 2010
- Enrollment
- 169 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.